Shisi Li1, Yanjun Chen1, Yingjie Mei2, Xianfu Mo1, Jialing Chen1, Yongqiang Li3, and Xiaodong Zhang1
1Department of Medical Imaging, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China, 2Philips Healthcare, Guangzhou, China, 3Department of Nephrology, The Third Affiliated Hospital of Southern Medical University (Academy of Orthopedics· Guangdong Province), Guangzhou, China
Synopsis
Renal fat content has been known as correlated with
renal injury in type 2 diabetes. However, it is not clear the change of renal
fat content in patients
with metabolic syndrome (MS), which is a more popular disease threatened human
health.
In
the present study, we assess the feasibility and reproducibility of renal fat
fraction (FF) using PDFF imaging with MR mDixon-Quant sequence. And we aim to investigate the changes of renal FF in patients with
MS, whose estimated glomerular filtration rate (eGFR) grade were G1(normal or
elevated) and G2(mild decline) described in KDIGO (Kidney Disease: Improving
Global Outcomes). In addition, we evaluate the correlation of renal FF and eGFR
and the major factors of eGFR. The results show that with eGFR decreasing, renal
FF in patients with MS-G2 group increased significantly compared with control
and MS-G1 group. And the renal FF is an important affection factor of eGFR with
a significant negative correlation.
The noninvasive quantitative Dixon-based MRI may be a new biomarker for
the evaluation of early renal impairment.
Background/Introduction
Metabolic syndrome(MS), as an important risk fator for
type 2 diabetes and cardiovascular, is a serious threat to human health. At
present, it is also considered as an independent risk factor for chronic kidney
disease(CKD). During obesity for MS
patients, surplus energy will be deposited in various tissues and organs in the
form of adipose and contributes to their damage through toxic processes named
lipotoxici [1, 2]. Therefore, accurate measurement of renal fat content in
patients with MS is of great significance for the evaluation of renal function
changes and the detection of early renal injury. MR PDFF imaging is an
invaluable tool for evaluation of fat content in kidney [3, 4]. In this study,
we explored the value of renal lipid content based on PDFF imaging for the
assessment of early renal injury in patients with metabolic syndrome, and investigate the relationship between renal FF and estimated glomerular
filtration rate (eGFR).Methods
24 MS patients (G1,
eGFR≥90ml, n=10; G2, 60≤ eGFR<90ml, n=14)and
23 non-MS volunteers were included. All participants received 3D multiecho
Dixon gradient-recalled echo sequence (mDixon-Quant) using a 3.0-T magnetic
resonance scanner (Ingenia, Philips Healthcare, Best, Netherlands). The FF of
renal, hepatic, perirenal adipose were measured(Fig.1a). And triglyceride(TG), high
density lipoprotein(HDL), low density lipoprotein(LDL), Serum creatinine(SCr),
cholesterol(Cho), waistline and eGFR were recorded. Statistical analysis was performed with one-way ANOVA,
bonferroni post-hoc analysis, repeatability test, multivariable analysis, and
Pearson correlation test.Results
Renal FF of MS-G2 group (5.34
±0.50%)was significantly higher than that of MS-G1group and non-MS groups
(4.61±0.58% and 3.83±0.55% respectively,
P<0.01) , shown as Figure 1 and 2. There was a significant negative correlation between eGFR and renal FF (r=-0.653,
P<0.01, in all participants, shown in Figure 3). Multi factor analysis
showed that Scr and renal FF were significantly correlated with eGFR (Model 1-2
R=0.778, 0.852 respectively). The repeatability of renal FF measurements was
high and with a good interclass correlation coefficient of 0.845 for observer A
and observer B(shown as Figure 4).Conclusion
The MS patients whose eGFR were mild decline had a
highest renal FF compared with MS patients with nomal or elevated eGFR and
healthy subjects. Renal fat deposition in patients with MS maybe majorly
contributed to the early decrease of eGFR. The noninvasive quantitative
Dixon-based MRI can be a new biomarker for the evaluation of early renal
impairment.Acknowledgements
Xiaodong Zhang and Yongqiang Li are both co-corresponding authors.
Funding: The National Natural Science Foundation of China (81801653), Science and Technology Planning Project of Guangdong Province (2017B090912006)
References
1.
Peng XG, Bai YY, Fang F, et al. Renal lipids and oxygenation in diabetic mice:
noninvasive quantification with MR imaging. Radiology 2013; 269(3):748–757.
2.
Weinberg JM. Lipotoxicity. Kidney Int2006;70(9):1560–1566
3.
Yokoo T, Clark HR, Pedrosa I, et al. Quantification of renal steatosis in type
II diabetes mellitus using Dixon-based MRI. J Magn Reson Imaging 2016;
44(5):1312–1319.
4. Wang
YC, Feng YL, Lu CQ, et al. Renal fat fraction and diffusion tensor imaging in patients
with early-stage diabetic nephropathy. Eur Radio 2018; 288(8):3326-3334.